(Q39262615)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

main subject

cytotoxicity

0 references

multiple drug resistance

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Holger Lode

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

C P Reynolds

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

2

Diana Seidel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1

Anastasia Shibina

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

9

Nicole Huebener

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Srinivas S Somanchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Alexander Stermann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Barry J Maurer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

30 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular Medicine

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

459-472

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052481%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00109-012-0958-0

10 March 2020

exact match

0 references

cites work

Genetic parameters of neuroblastomas

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Mechanisms of granule-dependent killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Apoptosis signaling by death receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Directing cancer cells to self-destruct with pro-apoptotic receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Glycosphingolipids and drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Short tandem repeat profiling provides an international reference standard for human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Expansion, purification, and functional assessment of human peripheral blood NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Improved oral delivery of N-(4-hydroxyphenyl)retinamide with a novel LYM-X-SORB organized lipid complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Inhibition of death receptor signals by cellular FLIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Altered sphingolipid metabolism in N-(4-hydroxyphenyl)-retinamide-resistant A2780 human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

MIC and other NKG2D ligands: from none to too many.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

FCGR2APolymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0958-0

An economical adaptation of the RosetteSep procedure for NK cell enrichment from whole blood, and its use with liquid nitrogen stored peripheral blood mononuclear cells

21 January 2018

1 reference

12 December 2020

Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord

1 reference

12 December 2020

Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines

1 reference

12 December 2020

A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a

1 reference

12 December 2020

Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.

1 reference

12 December 2020

Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma

1 reference

12 December 2020

Influence of cellular ganglioside depletion on tumor formation

1 reference

12 December 2020

Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients.

1 reference

12 December 2020

Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia

1 reference

12 December 2020